This quasi-experimental study evaluates whether a low-technology, pharmacist-inclusive Short Message Service (SMS) notification of final blood culture results improves the timeliness and appropriateness of antimicrobial therapy in a resource-limited tertiary care setting.
HemoAlert speeds up appropriate antimicrobial therapy for bacteremia.
Timely initiation of appropriate antimicrobial therapy is crucial for improving outcomes in patients with bacteremia. The HemoAlert notification program reduced time to appropriate therapy and increased appropriate therapy within 72 hours by 34.0% vs 22.7% (P = .03). The study suggests that notification systems like HemoAlert can significantly improve antimicrobial management, although the impact on mortality was not significant. The HemoAlert program enhances the timing and appropriateness of therapy in bacteremia patients.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:Phuetphaichit S, Samanloh S, Kamolvit W, Rattanaumpawan P
Citation:Phuetphaichit S, Samanloh S, Kamolvit W, et al. Impact of hemo-alert program on appropriate antimicrobial therapy in hospitalized patients with bacteremia: a quasi-experimental study. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e220. doi:10.1017/ash.2026.10757
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.